Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exelixis Inc (NQ: EXEL )

19.35 +0.08 (+0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,525,096
Open 19.27
Bid (Size) 19.35 (3)
Ask (Size) 19.90 (1)
Prev. Close 19.27
Today's Range 19.22 - 19.60
52wk Range 14.87 - 22.47
Shares Outstanding 315,048,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Farallon Capital Management Comments on Election of All Three of Its Nominees to Exelixis’ Board
From Farallon Capital Management L.L.C.
Via Business Wire
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in June
From Exelixis, Inc.
Via Business Wire

Performance

YTD
+18.71%
+18.71%
1 Month
+1.68%
+1.68%
3 Month
+18.28%
+18.28%
6 Month
+18.35%
+18.35%
1 Year
-0.62%
-0.62%

More News

Read More
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
Via The Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Via The Motley Fool
8 Analysts Have This to Say About Exelixis
Via Benzinga
Exelixis (EXEL) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Exelixis: Q1 Earnings Insights
Via Benzinga
What 9 Analyst Ratings Have To Say About Exelixis
Via Benzinga
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
Via MarketBeat
Exposures Product Safety
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip
Via The Motley Fool
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update
From Exelixis, Inc.
Via Business Wire
Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns
Via Benzinga
Farallon Capital Management Comments on Successful Campaign for Change at Exelixis
From Farallon Capital Management L.L.C.
Via Business Wire
Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors
From Exelixis, Inc.
Via Business Wire
Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023
From Exelixis, Inc.
Via Business Wire
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates
From Farallon Capital Management L.L.C.
Via Business Wire
Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
From Exelixis, Inc.
Via Business Wire
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From Exelixis, Inc.
Via Business Wire
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
Via The Motley Fool
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip
Via The Motley Fool
Exelixis Advances Board Refreshment Plan
From Exelixis, Inc.
Via Business Wire
Exelixis Reiterates Commitment to Shareholder Value Creation
From Exelixis, Inc.
Via Business Wire
2 Under-the-Radar Biotech Stocks to Buy in 2023
Via The Motley Fool
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.